Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease

详细信息    查看全文

• 作者：Hua Peng (1)
  Zubo Wu (1)
  Yalan Liu (1)
  Ling Li (2)
  Shuangshuang Kong (2)
  Jing Wu (3)
  Yali Liu (1)
  
  1. Pediatric Department ; Union Hospital ; Tongji Medical College ; Huang zhong University of Science and Technology ; Wuhan ; People鈥檚 Republic of China
  2. Ultrasound Department ; Union Hospital ; Tongji Medical College ; Huang zhong University of Science and Technology ; Wuhan ; People鈥檚 Republic of China
  3. Tongji Medical College ; Huang zhong University of Science and Technology ; Wuhan ; People鈥檚 Republic of China
  
• 关键词：Kawasaki disease ; Coronary thrombosis ; Antithrombotic treatment
• 刊名：Pediatric Cardiology
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：36
• 期：3
• 页码：503-508
• 全文大小：370 KB
• 参考文献：1. Bonduel MM (2006) Oral anticoagulation therapy in children. Thromb Res 118:85鈥?4 CrossRef
  2. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364:533鈥?44 CrossRef
  3. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144鈥?148 CrossRef
  4. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057鈥?061
  5. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145鈥?48 CrossRef
  6. Ebina T, Ishikawa Y, Uchida K, Suzuki S, Imoto K, Okuda J, Tsukahara K, Hibi K, Kosuge M, Sumita S, Mochida Y, Ishikawa T, Uchino K, Umemura S, Kimura K (2009) A case of giant coronary artery aneurysm and literature review. J Cardiol 53:293鈥?00 CrossRef
  7. Fukuhara S, Takase E, Fujimoto T, Takami Y, Yamamoto K, Nishida T, Morimoto A (2005) Coronary ectasia resulting in thrombotic coronary occlusion after warfarin interruption: a case report. J Cardiol 46:195鈥?00
  8. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T et al (1984) High-dose intravenous gamma globulin for Kawasaki disease. Lancet 2:1055鈥?058 CrossRef
  9. Gersony WM (1991) Diagnosis and management of Kawasaki disease. JAMA 265:2699鈥?703 CrossRef
  10. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)鈥攄igest version. Circ J 74:1989鈥?020
  11. Harada M, Akimoto K, Ogawa S, Kato H, Nakamura Y, Hamaoka K, Saji T, Shimizu T, Kato T (2013) National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease. Pediatr Int 55:690鈥?95 CrossRef
  12. Horigome H, Sekijima T, Miyamoto T (1997) Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart 78:517鈥?18 CrossRef
  13. Johnson PN, Kuhn RJ (2008) Combination thrombolytic and anti-platelet therapies in an infant with incomplete Kawasaki disease and coronary aneurysms. J Pediatr Pharmacol Ther 13:242鈥?50
  14. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379鈥?385 CrossRef
  15. Kobayashi H, Takazawa K, Matsumoto C, Ooi K, Nagata T, Katou K, Yoshida M, Aiga M, Aizawa A, Takahashi E, Namatame Y, Kinou M, Yamashina A (2006) The role of intravenous coronary thrombolysis for patients with acute myocardial infarction in different treatment strategies. Intern Med 45:709鈥?14 CrossRef
  16. Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388鈥?92 CrossRef
  17. Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S (2000) Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 42:470鈥?75 CrossRef
  18. Monagle P (2003) Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 29:547鈥?55 CrossRef
  19. Nakagawa M, Watanabe N, Okuno M, Okamoto N, Fujino H (2000) Effects of intracoronary tissue-type plasminogen activator treatment in Kawasaki disease and acute myocardial infarction. Cardiology 94:52鈥?7 CrossRef
  20. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341鈥?47 CrossRef
  21. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633鈥?639 CrossRef
  22. O鈥橞rien M, Parness IA, Neufeld EJ, Baker AL, Sundel RP, Newburger JW (2000) Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics 105:E64 CrossRef
  23. Okura N, Okuda T, Shiotani S, Kohno M, Hayakawa H, Suzuki A, Kawasaki T (2013) Sudden death as a late sequel of Kawasaki disease: postmortem CT demonstration of coronary artery aneurysm. Forensic Sci Int 225:85鈥?8 CrossRef
  24. Suzuki A, Kamiya T, Ono Y, Kohata T, Okuno M (1988) Myocardial ischemia in Kawasaki disease: follow-up study by cardiac catheterization and coronary angiography. Pediatr Cardiol 9:1鈥? CrossRef
  25. Tatara K, Kusakawa S (1987) Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 111:705鈥?10 CrossRef
  26. Terai M, Ogata M, Sugimoto K, Nagai Y, Toba T, Tamai K, Aotsuka H, Niwa K, Nakajima H (1985) Coronary arterial thrombi in Kawasaki disease. J Pediatr 106:76鈥?8 CrossRef
  27. Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79鈥?5 CrossRef
  28. Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 105:E78 CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  Cardiac Surgery
  Vascular Surgery
  
• 出版者：Springer New York
• ISSN：1432-1971

文摘

To explore effective and convenient rescue therapy options for coronary artery aneurysms (CAA) with thrombosis in Kawasaki disease (KD). A total of 210 patients with KD between the years 2003 and 2013 were retrospectively reviewed in our institute. 144 of these 210 KD developed CAA, and 10 patients with CAA had associated thrombosis. Thrombosis was confirmed by two-dimensional echocardiograms (2-DE). Laboratory values for CAA were analyzed with and without the thrombus group. The characteristics of CAA were monitored by ultrasound. All patients with thrombus received intravenous (IV) antithrombotic therapy, including urokinase, heparin, and oral warfarin. The effectiveness of antithrombotic treatment was evaluated by measuring the ability to dissolve the thrombus. All thrombi in these patients were preceded by a giant CAA and a history of KD. There are no differences in the blood analyses of both CAA with and without thrombus. Moreover, typical KD symptoms and acute myocardial infarction were not found in CAA with thrombosis. The progression of coronary thrombosis in these patients was arrested by antithrombotic and anti-platelet treatment including low-dose urokinase and heparin. Neither clinical features nor laboratory data could reliably predict CAA associated thrombosis. Therapy with IV anti-thrombus and anti-platelet treatment with low-dose warfarin can effectively dissolve thrombi in KD patients.